Key Differentiation
DeepTech Precision Beyond Conventional LNPs
Conventional LNPs
Enabled breakthrough therapies, but limited by consistency, stability, organ selectivity, immunogenicity, and reproducibility.
Structural InstabilityRandom liquid-phase assembly risks payload loss during storage and administration.
Toxicity & ImmunogenicityIonizable lipids can trigger inflammatory markers.
Liver AccumulationNon-specific delivery limits access to extra-hepatic organs.
Manufacturing VariabilityBatch-to-batch variation complicates scale-up.
EnsaliX-Designed pLNPs
Nanoprecision-printed to enhance consistency, delivery performance, stability, and translational readiness.
More Stable StructuresSemi-solid patterned assembly improves structural consistency.
Self-Targeting DeliveryLigand-free architecture enables targeted delivery.
Improved Safety ProfileIonizable lipid-free design reduces immunogenicity.
High UniformityMillions of features patterned simultaneously.
